Probabilistic antibiotic therapy of community-acquired peritonitis: Influence of the site;Antibiothérapie probabiliste des péritonites communautaires: Influence du site

Annales Francaises d'Anesthesie et de Reanimation

Volumn 20, Issue SUPPL. 2, 2001, Pages 427-440

  Leone, M ^a   Martin, C ^a  

^a HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; FLEROXACIN; GENTAMICIN; LATAMOXEF; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN; SULTAMICILLIN; TAZOBACTAM; TICARCILLIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; BACTERIUM ISOLATION; CITROBACTER FREUNDII; COLON PERFORATION; CONFERENCE PAPER; DRUG CHOICE; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; HUMAN; INTESTINE INFARCTION; MORTALITY; PATHOPHYSIOLOGY; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STOMACH PERFORATION;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PERITONEUM; PERITONITIS;

EID: 17144467942     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (80)

1. Bacteria and septic complications in patients with perforated duodenal ulcers
2. Clinical significance of Candida isolated from peritoneum in surgical patients
3. Péritonites communautaires et nosocomiales
4. Peritonitis and other intra-abdominal infections
5. The bacteriology of intra-abdominal infections
6. The bacteriology of intra-abdominal infections
7. The role of Pseudomonas species in patients treated with ampicilin and sulbactam for gangrenous and perforated appendicitis
8. The role of Candida in intraperitoneal infections
9. Experimental intra-abdominal abcesses in rats. Development of an experimental model
10. Microbial synergy in experimental intra abdominal abscess
11. Experimental intra-abdominal abscesses in rats. Quantitative bacteriology of infected animals
12. Pathogenicity of entroccoci in a rat model of fecal peritonis
13. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis
14. Reciprocal synergy between Escherichia coli and Bacteroides in an intra-abdominal infection model
15. Antimicrobial therapy of experimental intra-abdominal sepsis
16. Therapy of infections caused by mixed of Escherichia coli and Steptococcus faecalis
17. Effects of clindamycin and gentamicin and other anti-microbial combinations against enteroccci in an experimental model of intra-abdominal abscess
18. Effects of clindamycin and metronidazole on intestinal colonization and translocation of enteroccoci in mice
19. Pathogenicity of the Enterococcus in surgical infections
20. Enterococcus, an emerging pathogen
21. Enterococcal bacteremia in surgical patients
22. Evidence for the translocation of Enterococcus faecalis across the mouse intestical tract
23. Pathogenicity of enterococci in a rat model of fecal peritonitis
24. Development of β-lactam resistant Enterobacter cloacae in mice
25. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model
26. Emergence of resistance during β-lactam therapy of Gram-negative infections. Bacterial mechanisms and medical responses
27. Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses
28. Therapeutic efficacy of 29 antimicrobial regimens in experimental intra-abdominal sepsis
29. A review: Lessons from an animal model of intra-abdominal sepsis
30. L'antibiothérapie des syndromes péritonéaux
31. Antibiotic treatment for surgical peritonitis
32. Les péritonites aiguës: Physiopathologie et principes thérapeutiques
33. Guidelines for clinical care: Anti infective agents for intra-abdominal infection
34. Bacteroides fragilis: État de la sensibilité aux antibiotiques, évolution des résistances
35. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections
36. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections
37. Treatment of intraabdominal infections is appropriate with single-agent or combination antibiotic therapy
38. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections
39. Management of intra-abdominal infections
40. Étude de la sensibilité à l'Augmentin de 998 souches de Escherichia coli isolées dans quatre centres hospitaliers français (Étude Colicerib I)
41. Clinical isolates of Escherichia coli producing TRI Beta-lactamases: Novel TEM-enzymes conferring resistance to Beta-lactamase inhibitors
42. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients
43. Antibiotic therapy of intra-abdominal sepsis in the elderly: Experience with ticarcillin and clavulanic acid
44. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis
45. Short-term antibiotherapy for peritonitis: Prospective, randomized trial comparing cefotaxime-metronidazole and clindamycin-tobramycin
46. Ciprofloxacin vs. cefotaxime regimens for the treatment of intra-abdominal infections
47. Cefotaxime and metronidazole in severe intra-abdominal infection
48. A randomized clinical trial of ampicillin, gentamicin and clindamycin in children with ruptured appendicitis
49. Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections
50. Comparacion prospectiva, aleatoria y abierta de meropenem frente a cefotaxima y metronidazol en el tratamiento de las infecciones intraabdominales
51. A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis
52. Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections
53. Traitement empirique des infections intra-abdominales sévères: Étude multicentrique comparative de l'efficacité de l'imipénème/cilastatine et de la ceftazidime
54. Can oral metronidazole substitute parenteral drug therapy in acute appendicitis? A new policy in the management of simple or complicated appendicitis with localized peritonitis: A randomized controlled clinical trial
55. A comparative study of cefamandole versus gentamicin plus clindamycin in the treatment of documented or suspected bacterial peritonitis
56. A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections
57. Treatment of acute bacterial peritonitis: A trial of imipenem/cilastatin against ampicilli-metronidazole-gentamicin
58. Imipenem-cilastatin vs tobramycin and metronidazole for appendicitis-related infections
59. Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis
60. Diffuse peritonitis treated with tobramycin and clindamycin. Bacteria in relation to preoperative duration of illness
61. High-dose tobramycin combined with cindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis
62. Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections
63. A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intraabdominal infections
64. Antibiotic therapy of perforated appendicitis in children: A comparison of amoxicillin/clavulanate with a combination of benzylpenicillin, netilmicin and metronidazole
65. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections
66. The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections
67. Prospective, randomized comparisons of metronidazole and clindamycin, each with gentamicin, for the treatment of serious intra-abdominal infection
68. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for treatment pf intra-abdominal infections
69. Aztreonam plus clindamycin vs. Tobramycin plus clindamycin for the treatment of intraabdominal infections
70. Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin
71. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections
72. Pourquoi, quand et comment prescrire une association d'antibiotiques
73. Choix d'un antibiotique pour le traitement d'une infection à streptocoque ou entérocoque
74. Treatment of intra-abdominal infections in appropriate with single-agent or combination antibiotic therapy
75. Comparaison de deux associations d'antibiotiques au cours des péritonites: Cèfotaxime + clindamycine versus céfotaxime + métronidazole
76. A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections
77. A randomised prospective controlled study of ciprofloxacin with metronidazole versus amoxicillin/clavulanic acid with metronidazole in the treatment of intra-abdominal infection
78. Carbapenems: Monotherapy in intra-abdominal sepsis
79. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery
80. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections requiring surgery